NCT06378008View on ClinicalTrials.gov

A Clinical Study to Evaluate the Anti-Sensitivity Effect of a Calcium Sodium Phosphosilicate Toothpaste in a Population of Dentin Hypersensitivity Sufferers

NACompletedINTERVENTIONAL

Enrollment

217

Participants

Timeline

Start Date

April 16, 2024

Primary Completion Date

September 4, 2024

Study Completion Date

September 4, 2024

Conditions

Dentin Sensitivity

Interventions

DRUG

CSPS toothpaste

Toothpaste containing 5.0% weight/weight (w/w) CSPS.

DRUG

Regular fluoride toothpaste (Crest Cavity Protection)

Regular fluoride toothpaste containing 1100 parts per million (ppm) fluoride.

Trial Locations (1)

L5N 6J2

All Sum Research, Mississauga

All Listed Sponsors

lead

HALEON

INDUSTRY

NCT06378008 - A Clinical Study to Evaluate the Anti-Sensitivity Effect of a Calcium Sodium Phosphosilicate Toothpaste in a Population of Dentin Hypersensitivity Sufferers | Biotech Hunter | Biotech Hunter